WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the People's Republic of China, North America, Europe, and internationally. The company also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sale of medicals; vaccine CDMO and related business; and material supplier activities. WuXi Biologics (Cayman) Inc. has strategic partnership with ImmuneOncia Therapeutics, Legochem Biosciences Inc, Worg Pharma, OncoC4, and Exelixis Inc. The company was incorporated in 2014 and is headquartered in Wuxi, China.

WuXi Biologics (Cayman) Inc.

Revenue

Price Targets

# of Analysts

Consensus Recommendation

EBITDA

EBIT

Free Cash Flow

FFO / Share

AFFO / Share

NAV / Share

Book Value / Share

CapEx

Estimates	Dec '23 (A)	Dec '24 (A)	Dec '25 (E)
Mean	CN¥16,840.82	CN¥17,994.46	CN¥21,518.03
Median	CN¥16,834.63	CN¥18,071.76	CN¥21,501.00
Actual	CN¥17,034.26	CN¥18,675.37	—
High	CN¥17,044.04	CN¥18,501.00	CN¥22,455.55
Low	CN¥16,703.42	CN¥16,503.00	CN¥21,161.00
Standard Deviation	CN¥66.20	CN¥378.79	CN¥231.44
# of Estimates	28	27	27